• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司洗脱生物可吸收镁合金支架增强预防再狭窄的疗效。

Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention of restenosis.

机构信息

Department of Radiology, First Affiliated Hospital of China Medical University, Key Laboratory of Diagnostic Imaging and Interventional Radiology, Liaoning Province.

出版信息

J Endovasc Ther. 2011 Jun;18(3):407-15. doi: 10.1583/10-3353.1.

DOI:10.1583/10-3353.1
PMID:21679083
Abstract

PURPOSE

To determine the efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents (SEBMAS) in restenosis prevention.

METHODS

A balloon-expandable bioabsorbable magnesium alloy stent (BMAS) was created and coated with biodegradable poly(lactic acid-co-trimethylene carbonate) that contained the antiproliferative drug sirolimus (140 ± 40 µg/cm²). Both the uncoated BMAS and the coated SEBMAS were deployed 2 cm apart in balloon-injured infrarenal abdominal aortas of 20 New Zealand white rabbits. The stented aortic segments were removed at 30, 60, 90, and 120 days (5 rabbits per interval) after implantation. The average stent strut sectional area of each group was measured to evaluate the degree of magnesium corrosion and to forecast the biodegradation time profile of the magnesium stent. Histology and histopathology of the sectioned stented aortic segments were performed to evaluate neointima formation, endothelialization, and inflammation.

RESULTS

The SEBMAS degraded gradually after being implanted into the rabbit aorta, and total biocorrosion occurred after ~120 days. In all groups, the lumen area was significantly greater, but the neointimal area was significantly smaller in SEBMAS segments compared with the uncoated BMAS segments (p < 0.05) at all time points. There was no significant difference in the injury or inflammation scores between the groups. Endothelialization was delayed at 30 days in the SEBMAS segments vs. the uncoated BMAS segments.

CONCLUSION

SEBMAS further reduces intimal hyperplasia and improves the lumen area when compared to uncoated BMAS; however, it delays vascular healing and endothelialization.

摘要

目的

评估西罗莫司洗脱可生物吸收镁合金支架(SEBMAS)在预防再狭窄方面的疗效。

方法

制作了一种球囊扩张可生物吸收镁合金支架(BMAS),并在其表面涂覆了含有抗增殖药物西罗莫司(140 ± 40 µg/cm²)的可生物降解聚(乳酸-co-三亚甲基碳酸酯)。将未涂层的 BMAS 和涂层的 SEBMAS 分别在 20 只新西兰白兔的腹主动脉损伤部位进行 2 cm 间隔部署。在植入后 30、60、90 和 120 天(每组 5 只兔子)时取出支架的主动脉段。测量每组支架的平均支架支柱截面积,以评估镁腐蚀的程度,并预测镁支架的生物降解时间曲线。对分段支架主动脉段进行组织学和组织病理学检查,以评估新生内膜形成、内皮化和炎症情况。

结果

SEBMAS 植入兔主动脉后逐渐降解,约 120 天后完全生物腐蚀。在所有时间点,SEBMAS 段的管腔面积明显大于未涂层的 BMAS 段,但新生内膜面积明显小于后者(p < 0.05)。各组之间的损伤或炎症评分无显著差异。与未涂层的 BMAS 段相比,SEBMAS 段在 30 天时内皮化延迟。

结论

与未涂层的 BMAS 相比,SEBMAS 进一步减少了内膜增生,增加了管腔面积;然而,它延迟了血管愈合和内皮化。

相似文献

1
Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention of restenosis.西罗莫司洗脱生物可吸收镁合金支架增强预防再狭窄的疗效。
J Endovasc Ther. 2011 Jun;18(3):407-15. doi: 10.1583/10-3353.1.
2
Commentary: Deliver the drug and disappear: is the bioabsorbable magnesium stent growing up or still shrinking?评论:给药后消失:可生物吸收镁支架是在成长还是仍在萎缩?
J Endovasc Ther. 2011 Jun;18(3):416-7. doi: 10.1583/10-3353C.1.
3
The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.转染血管内皮生长因子的人内皮细胞对不锈钢支架内皮化和再狭窄的影响。
J Vasc Surg. 2011 Feb;53(2):461-71. doi: 10.1016/j.jvs.2010.08.020. Epub 2010 Dec 3.
4
In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.在球囊去内皮和辐射致高胆固醇血症兔髂动脉中,比较无聚合物的依维莫司 A9 洗脱支架与生物可降解聚合物基依维莫司 A9 洗脱支架和裸金属支架的体内情况。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):429-36. doi: 10.1002/ccd.23407. Epub 2011 Dec 1.
5
Biodegradable Magnesium Alloy Stents as a Treatment for Vein Graft Restenosis.可生物降解镁合金支架治疗静脉桥再狭窄
Yonsei Med J. 2019 May;60(5):429-439. doi: 10.3349/ymj.2019.60.5.429.
6
Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.在猪冠状动脉支架植入模型中比较生物可降解聚合物和永久性聚合物载有西罗莫司的药物洗脱支架的组织病理学表现。
Thromb Haemost. 2012 Jun;107(6):1161-71. doi: 10.1160/TH12-01-0043. Epub 2012 Apr 26.
7
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).首例人体生物可吸收聚合物涂层依维莫司洗脱支架的评估:DESOLVE I 试验(载有依维莫司和生物可吸收聚合物的 DES 治疗原发性冠状动脉病变患者)的影像学和临床结果。
JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.
8
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.ENDEAVOR IV试验的血管内超声结果:冠心病患者中佐他莫司洗脱支架与紫杉醇洗脱支架的随机对照比较
JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015.
9
Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.姜黄素预防高胆固醇血症兔髂动脉支架再狭窄的作用。
Catheter Cardiovasc Interv. 2009 Nov 15;74(6):881-8. doi: 10.1002/ccd.22047.
10
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.基于聚合物和非聚合物的西罗莫司洗脱支架的不同愈合反应
JACC Cardiovasc Interv. 2008 Oct;1(5):535-44. doi: 10.1016/j.jcin.2008.08.004.

引用本文的文献

1
Mechanically robust neuroprotective stent by sequential Mg ions release for ischemic stroke therapy.用于缺血性中风治疗的通过顺序释放镁离子实现机械坚固的神经保护支架。
Nat Commun. 2025 Jul 16;16(1):6557. doi: 10.1038/s41467-025-61199-x.
2
Synchrotron microtomography reveals insights into the degradation kinetics of bio-degradable coronary magnesium scaffolds.同步加速器显微断层扫描揭示了可生物降解冠状动脉镁支架的降解动力学。
Bioact Mater. 2023 Sep 23;32:1-11. doi: 10.1016/j.bioactmat.2023.09.008. eCollection 2024 Feb.
3
In vitro and in vivo evaluation of a novel bioresorbable magnesium scaffold with different surface modifications.
新型生物可吸收镁支架不同表面改性的体外和体内评价。
J Biomed Mater Res B Appl Biomater. 2021 Sep;109(9):1292-1302. doi: 10.1002/jbm.b.34790. Epub 2021 Jan 1.
4
Biodegradable Magnesium Alloy Stents as a Treatment for Vein Graft Restenosis.可生物降解镁合金支架治疗静脉桥再狭窄
Yonsei Med J. 2019 May;60(5):429-439. doi: 10.3349/ymj.2019.60.5.429.
5
Intermediate analysis of magnesium alloy covered stent for a lateral aneurysm model in the rabbit common carotid artery.兔颈总动脉外侧动脉瘤模型用镁合金覆膜支架的中期分析。
Eur Radiol. 2017 Sep;27(9):3694-3702. doi: 10.1007/s00330-016-4715-6. Epub 2017 Jan 26.
6
In vivo response of AZ31 alloy as biliary stents: a 6 months evaluation in rabbits.体内 AZ31 合金作为胆道支架的反应:兔 6 个月评估。
Sci Rep. 2017 Jan 13;7:40184. doi: 10.1038/srep40184.
7
Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.镁合金支架与血管之间的生物适应性:综述
J Mater Sci Technol. 2016 Sep;32(9):815-826. doi: 10.1016/j.jmst.2015.12.018. Epub 2015 Dec 24.
8
Degraded and osteogenic properties of coated magnesium alloy AZ31; an experimental study.涂层镁合金AZ31的降解和成骨特性:一项实验研究。
J Orthop Surg Res. 2016 Mar 14;11:30. doi: 10.1186/s13018-016-0362-5.
9
Sirolimus-eluting dextran and polyglutamic acid hybrid coatings on AZ31 for stent applications.用于支架应用的AZ31上的西罗莫司洗脱葡聚糖和聚谷氨酸混合涂层。
J Biomater Appl. 2015 Nov;30(5):579-88. doi: 10.1177/0885328215596324. Epub 2015 Jul 21.
10
The effects of novel, bioresorbable scaffolds on coronary vascular pathophysiology.新型生物可吸收支架对冠状动脉病理生理学的影响。
J Cardiovasc Transl Res. 2014 Jun;7(4):413-25. doi: 10.1007/s12265-014-9571-7. Epub 2014 May 7.